Arisa Akashi Sin
Lawyers
Filters
Bristol-Myers Squibb Company $19 Billion Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $19 billion in aggregate principal amount of senior notes by Bristol-Myers…
Watford Holdings Ltd. Direct Listing
Davis Polk advised the financial advisers to Watford Holdings Ltd. in connection with Watford’s direct listing of its common shares on the Nasdaq Global Select Market. The common shares are…
Alnylam Pharmaceuticals, Inc. $387.5 Million Common Stock Offering
Davis Polk advised the sole book-running manager of a $387.5 million SEC-registered offering of 5,000,000 shares of common stock of Alnylam Pharmaceuticals, Inc. Alnylam’s common stock is…